ABEONA THERAPEUTICS INC. Debt Instrument, Interest Rate, Stated Percentage
ABEONA THERAPEUTICS INC. (ABEO) had Debt Instrument, Interest Rate, Stated Percentage of 1.00% as of 2020-05-02, per its 10-Q filed 2020-08-10.
Discontinued › Notes › Debt Instruments
us-gaap:DebtInstrumentInterestRateStatedPercentage · last filed 2020-08-10
- 2020-05-02: Debt Instrument, Interest Rate, Stated Percentage 1.00%.
- 2011-12-31: Debt Instrument, Interest Rate, Stated Percentage 12.00%.
| Period end | Debt Instrument, Interest Rate, Stated Percentage |
|---|---|
| 2020-05-02 | 1.00% 10-Q · filed 2020-08-10 |
| 2011-12-31 | 12.00% 10-K · filed 2014-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |